Jing S, Wang H, Lin P, Yuan J, Tang Z, Li H
NPJ Precis Oncol. 2025; 9(1):68.
PMID: 40069556
PMC: 11897387.
DOI: 10.1038/s41698-025-00857-1.
Millward J, He Z, Nibali A, Mouradov D, Mielke L, Tran K
J Transl Med. 2025; 23(1):298.
PMID: 40065354
PMC: 11892243.
DOI: 10.1186/s12967-025-06254-3.
Arslan D, Sehlaver S, Guder E, Temena M, Bahcekapili A, Ozdemir U
Heliyon. 2025; 11(4):e42467.
PMID: 40061913
PMC: 11889546.
DOI: 10.1016/j.heliyon.2025.e42467.
Liang X, Deng M, Zhu Z, Zhang W, Li Y, Luo J
Int J Legal Med. 2025; .
PMID: 40019556
DOI: 10.1007/s00414-025-03447-9.
Xie Y, Liu F, Wu Y, Zhu Y, Jiang Y, Wu Q
Mol Cancer. 2025; 24(1):51.
PMID: 39994787
PMC: 11849313.
DOI: 10.1186/s12943-025-02243-8.
Empowering cancer research in Europe: the EUCAIM cancer imaging infrastructure.
Marti-Bonmati L, Blanquer I, Tsiknakis M, Tsakou G, Martinez R, Capella-Gutierrez S
Insights Imaging. 2025; 16(1):47.
PMID: 39992532
PMC: 11850660.
DOI: 10.1186/s13244-025-01913-x.
Systematic inference of super-resolution cell spatial profiles from histology images.
Zhang P, Gao C, Zhang Z, Yuan Z, Zhang Q, Zhang P
Nat Commun. 2025; 16(1):1838.
PMID: 39984438
PMC: 11845739.
DOI: 10.1038/s41467-025-57072-6.
Integrating radiomics, pathomics, and biopsy-adapted immunoscore for predicting distant metastasis in locally advanced rectal cancer.
Zhao R, Shen W, Zhao W, Peng W, Wan L, Chen S
ESMO Open. 2025; 10(3):104102.
PMID: 39951928
PMC: 11874550.
DOI: 10.1016/j.esmoop.2024.104102.
Safety and efficacy of neoadjuvant therapy with tislelizumab plus chemotherapy for locally advanced head and neck squamous cell carcinoma: a single-arm, retrospective study.
Liang H, Liang W, Tian J, Zheng S, Su Y, Huang P
Cancer Immunol Immunother. 2025; 74(3):108.
PMID: 39932534
PMC: 11813832.
DOI: 10.1007/s00262-025-03953-0.
Biological correlates associated with high-risk breast cancer patients identified using a computational method.
Oh J, Pareja F, Elkin R, Xu K, Norton L, Deasy J
NPJ Breast Cancer. 2025; 11(1):8.
PMID: 39875417
PMC: 11775240.
DOI: 10.1038/s41523-025-00725-y.
Deep learning uncovers histological patterns of YAP1/TEAD activity related to disease aggressiveness in cancer patients.
Schmauch B, Cabeli V, Domingues O, Le Douget J, Hardy A, Belbahri R
iScience. 2025; 28(1):111638.
PMID: 39868035
PMC: 11758823.
DOI: 10.1016/j.isci.2024.111638.
Towards H&E Referenced Multiplex Immunofluorescence Interpretation: Spatial Co-localization, Cell Feature Validation, and Virtual H&E Generation.
Wang C, Jiang J, Moore R, Novotny B, Guo R, Fogarty Z
Res Sq. 2025; .
PMID: 39866878
PMC: 11760245.
DOI: 10.21203/rs.3.rs-5619126/v1.
Harnessing Artificial Intelligence to Enhance Global Breast Cancer Care: A Scoping Review of Applications, Outcomes, and Challenges.
Chia J, He G, Ngiam K, Hartman M, Ng Q, Goh S
Cancers (Basel). 2025; 17(2).
PMID: 39857979
PMC: 11764353.
DOI: 10.3390/cancers17020197.
Application progress of artificial intelligence in tumor diagnosis and treatment.
Sun F, Zhang L, Tong Z
Front Artif Intell. 2025; 7():1487207.
PMID: 39845097
PMC: 11753238.
DOI: 10.3389/frai.2024.1487207.
The global trends and distribution in tumor-infiltrating lymphocytes over the past 49 years: bibliometric and visualized analysis.
Wu B, Luo D, Wang X, Qiao C, Li R, Liu J
Front Immunol. 2025; 15():1511866.
PMID: 39835135
PMC: 11743541.
DOI: 10.3389/fimmu.2024.1511866.
Intratumoral microbiota, fatty acid metabolism, and tumor microenvironment constitute an unresolved trinity in colon adenocarcinoma.
Liu G, Liu K, Ji L, Li Y
Sci Rep. 2025; 15(1):2568.
PMID: 39833403
PMC: 11747563.
DOI: 10.1038/s41598-025-87194-2.
PHARAOH: A collaborative crowdsourcing platform for phenotyping and regional analysis of histology.
Faust K, Chen M, Babaei Zadeh P, Oreopoulos D, Leon A, Paliwal A
Nat Commun. 2025; 16(1):742.
PMID: 39820318
PMC: 11739387.
DOI: 10.1038/s41467-024-55780-z.
Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy: a multidimensional approach.
Lopez de Rodas M, Villalba-Esparza M, Sanmamed M, Chen L, Rimm D, Schalper K
Nat Rev Clin Oncol. 2025; 22(3):163-181.
PMID: 39820025
DOI: 10.1038/s41571-024-00984-x.
Preliminary characterisation of the spatial immune and vascular environment in triple negative basal breast carcinomas using multiplex fluorescent immunohistochemistry.
Takano E, Jana M, Lara Gonzalez L, Pang J, Salgado R, Loi S
PLoS One. 2025; 20(1):e0317331.
PMID: 39792888
PMC: 11723538.
DOI: 10.1371/journal.pone.0317331.
Mutation in CDC42 Gene Set as a Response Biomarker for Immune Checkpoint Inhibitor Therapy.
Wang K, Zhang Y, Su Z, Wang B, Zhou Y, Tong X
Cancer Med. 2025; 14(1):e70556.
PMID: 39791593
PMC: 11719708.
DOI: 10.1002/cam4.70556.